Physalin H exhibits significant anti-inflammatory and immunomodulatory properties, making it a compound of interest in therapeutic research. It has demonstrated potent activity in suppressing pro-inflammatory cytokines, which may be beneficial in treating chronic inflammatory diseases such as arthritis and inflammatory bowel disease. Additionally, Physalin H shows antitumor potential by inducing apoptosis in certain cancer cell lines, particularly in leukemia and hepatocellular carcinoma, suggesting its role in oncology drug development. Its ability to interfere with viral replication also highlights potential antiviral applications, especially against enveloped viruses. Due to its bioactivity, Physalin H is being studied as a lead compound for developing novel pharmaceutical agents targeting immune disorders, cancer, and viral infections.